149 related articles for article (PubMed ID: 28093709)
1. Molecular Genetic and Epigenetic Basis of Multiple Sclerosis.
Hojati Z
Adv Exp Med Biol; 2017; 958():65-90. PubMed ID: 28093709
[TBL] [Abstract][Full Text] [Related]
2. The potential role of epigenetic modifications in the heritability of multiple sclerosis.
Zhou Y; Simpson S; Holloway AF; Charlesworth J; van der Mei I; Taylor BV
Mult Scler; 2014 Feb; 20(2):135-40. PubMed ID: 24493701
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics of multiple sclerosis: an updated review.
Küçükali Cİ; Kürtüncü M; Çoban A; Çebi M; Tüzün E
Neuromolecular Med; 2015 Jun; 17(2):83-96. PubMed ID: 24652042
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Modifications and Therapy in Multiple Sclerosis.
Aslani S; Jafari N; Javan MR; Karami J; Ahmadi M; Jafarnejad M
Neuromolecular Med; 2017 Mar; 19(1):11-23. PubMed ID: 27382982
[TBL] [Abstract][Full Text] [Related]
5. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
6. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
7. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
Batoulis H; Addicks K; Kuerten S
Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic mechanisms and experimental models of multiple sclerosis.
Slavin A; Kelly-Modis L; Labadia M; Ryan K; Brown ML
Autoimmunity; 2010 Nov; 43(7):504-13. PubMed ID: 20380590
[TBL] [Abstract][Full Text] [Related]
10. Immunology of multiple sclerosis.
Williams KC; Ulvestad E; Hickey WF
Clin Neurosci; 1994; 2(3-4):229-45. PubMed ID: 7749893
[TBL] [Abstract][Full Text] [Related]
11. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
Holmøy T
Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
[TBL] [Abstract][Full Text] [Related]
12. Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?
Ruhrmann S; Stridh P; Kular L; Jagodic M
Int J Biochem Cell Biol; 2015 Oct; 67():49-57. PubMed ID: 26002250
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention.
Rito Y; Torre-Villalvazo I; Flores J; Rivas V; Corona T
Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):8-15. PubMed ID: 26915659
[TBL] [Abstract][Full Text] [Related]
14. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
Jadidi-Niaragh F; Mirshafiey A
Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
Aharoni R
J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
[TBL] [Abstract][Full Text] [Related]
16. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
17. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
Ji Q; Goverman J
Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).
Burrell AM; Handel AE; Ramagopalan SV; Ebers GC; Morahan JM
Discov Med; 2011 Mar; 11(58):187-96. PubMed ID: 21447278
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modifications in brain and immune cells of multiple sclerosis patients.
Castro K; Casaccia P
Mult Scler; 2018 Jan; 24(1):69-74. PubMed ID: 29307300
[TBL] [Abstract][Full Text] [Related]
20. Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis.
Wang X; Haroon F; Karray S; Martina Deckert ; Schlüter D
Eur J Immunol; 2013 Jan; 43(1):115-24. PubMed ID: 23011975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
